| 000 | 01759 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515050438.0 | ||
| 264 | 0 | _c20070213 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0893-0341 | ||
| 024 | 7 |
_a10.1097/01.wad.0000213845.28624.f4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGreenberg, Steven M | |
| 245 | 0 | 0 |
_aA phase 2 study of tramiprosate for cerebral amyloid angiopathy. _h[electronic resource] |
| 260 |
_bAlzheimer disease and associated disorders _c |
||
| 300 |
_a269-74 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aCerebral Amyloid Angiopathy _xcomplications |
| 650 | 0 | 4 |
_aCerebral Hemorrhage _xetiology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGABA Agonists _xadverse effects |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTaurine _xadverse effects |
| 700 | 1 | _aRosand, Jonathan | |
| 700 | 1 | _aSchneider, Alexander T | |
| 700 | 1 | _aCreed Pettigrew, L | |
| 700 | 1 | _aGandy, Samuel E | |
| 700 | 1 | _aRovner, Barry | |
| 700 | 1 | _aFitzsimmons, Brian-Fred | |
| 700 | 1 | _aSmith, Eric E | |
| 700 | 1 | _aEdip Gurol, M | |
| 700 | 1 | _aSchwab, Kristin | |
| 700 | 1 | _aLaurin, Julie | |
| 700 | 1 | _aGarceau, Denis | |
| 773 | 0 |
_tAlzheimer disease and associated disorders _gvol. 20 _gno. 4 _gp. 269-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.wad.0000213845.28624.f4 _zAvailable from publisher's website |
| 999 |
_c16703531 _d16703531 |
||